GlassScriptPhysician profile
Cassandra Graben
NPI 1689280661
$1,354.38
in general payments reported to CMS, 2019-2025
26 companies · $418 in 2025
The $418 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $317 · 2022: $213 · 2023: $104 · 2024: $303 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $257.62 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $194.63 | 2021-2022 | |
| Inari Medical, INC. | $147.19 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Solventum Corporation | $97.55 | 2025 | Activ.A.C. |
| Kci USA, INC. | $50.85 | 2021-2023 | V.A.C. Veraflo, 3m Coban, Promogran Prisma |
| Innocoll Pharmaceuticals Limited | $50.17 | 2022 | |
| Medtronic, INC. | $48.26 | 2022-2023 | Everflex |
| Vertex Pharmaceuticals Incorporated | $46.28 | 2025 | |
| Stryker Corporation | $40.49 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Venacore Thrombectomy Catheter |
| Lemaitre Vascular, INC. | $39.92 | 2025 | Artegraft Vascular Graft, Xenosure Biologic Patch |
| Shockwave Medical, INC | $39.33 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Organogenesis INC. | $38.93 | 2024-2025 | Affinity, Cygnus Dual |
| Bone Support INC. | $37.82 | 2025 | Cerament G, Ceramentbone Void Filler |
| Smith+Nephew, INC. | $33.45 | 2021-2024 | Collagenase Santyl, Regranex |
| Takeda Pharmaceuticals U.S.A., INC. | $32.79 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $30.26 | 2022-2024 | Lynparza, Keytruda |
| Paratek Pharmaceuticals, INC. | $27.91 | 2023-2024 | Nuzyra |
| Hologic INC | $21.30 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $20.08 | 2023 | Libtayo |
| Cvrx, INC. | $19.12 | 2023 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $15.78 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Pfizer INC. | $15.63 | 2021 | |
| Teleflex LLC | $15.07 | 2025 | Arrow |
| Boston Scientific Corporation | $14.65 | 2022 | |
| Genentech USA, INC. | $10.79 | 2021 | |
| Surmodics, INC. | $8.51 | 2025 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Graben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.